Weight Loss News and Research

Latest Weight Loss News and Research

Exploring the potential of mosaic RBD nanoparticles to fight SARS-CoV-2

Exploring the potential of mosaic RBD nanoparticles to fight SARS-CoV-2

Broad-spectrum antiviral activity of picolinic acid against SARS-CoV-2 and Influenza A virus

Broad-spectrum antiviral activity of picolinic acid against SARS-CoV-2 and Influenza A virus

Novel ACE2-blocking antibody protects against all SARS-CoV-2 VOCs

Novel ACE2-blocking antibody protects against all SARS-CoV-2 VOCs

Study suggests non-classical inhibition of TBK1/IKKε is protective against severe COVID-19 immunopathology in vivo

Study suggests non-classical inhibition of TBK1/IKKε is protective against severe COVID-19 immunopathology in vivo

Impact of COVID-19 lockdown on BMI of obese and normal-weight children in Switzerland

Impact of COVID-19 lockdown on BMI of obese and normal-weight children in Switzerland

Study reports a highly attenuated SARS-CoV-2 that could serve as a live-attenuated vaccine platform

Study reports a highly attenuated SARS-CoV-2 that could serve as a live-attenuated vaccine platform

ChAdOx1 vaccine found to protect Syrian hamsters against SARS-CoV-2 variants

ChAdOx1 vaccine found to protect Syrian hamsters against SARS-CoV-2 variants

Research lays the foundation for developing obesity drugs based on enhancing β-AR signaling

Research lays the foundation for developing obesity drugs based on enhancing β-AR signaling

Study describes a β-CoV spike protein target for protective antibodies that may facilitate pan-β-CoV vaccine development

Study describes a β-CoV spike protein target for protective antibodies that may facilitate pan-β-CoV vaccine development

mRNA-1273 and mRNA-1273.529 Omicron-specific boosters highly effective in mouse model

mRNA-1273 and mRNA-1273.529 Omicron-specific boosters highly effective in mouse model

Nitazoxanide shows promise for COVID-19 treatment in animal model

Nitazoxanide shows promise for COVID-19 treatment in animal model

Researchers develop influenza virus-like particle-based hybrid vaccine for both influenza and SARS-CoV-2 viruses

Researchers develop influenza virus-like particle-based hybrid vaccine for both influenza and SARS-CoV-2 viruses

Weight loss by overweight and obese people associated with reduced risk of colorectal adenoma

Weight loss by overweight and obese people associated with reduced risk of colorectal adenoma

Novel “prime and spike” vaccine strategy leverages existing immunity generated by primary COVID-19 vaccination

Novel “prime and spike” vaccine strategy leverages existing immunity generated by primary COVID-19 vaccination

Metabolic adaptation increases the length of time to achieve weight-loss goals

Metabolic adaptation increases the length of time to achieve weight-loss goals

Broad and potent neutralizing activity of human IgG1 LALA antibody against SARS-CoV-2 variants

Broad and potent neutralizing activity of human IgG1 LALA antibody against SARS-CoV-2 variants

Characterization of unique pathogenesis of SARS-CoV-2 Delta variant in mouse model

Characterization of unique pathogenesis of SARS-CoV-2 Delta variant in mouse model

Novel SARS-CoV-2 mutations reported in chronic HIV patients

Novel SARS-CoV-2 mutations reported in chronic HIV patients

Study finds Omicron infection effectively induces immunity against itself and enhances protection against other variants in vaccinated individuals

Study finds Omicron infection effectively induces immunity against itself and enhances protection against other variants in vaccinated individuals

Investigational cancer drug mimics the metabolic and therapeutic effects of fasting, mice study shows

Investigational cancer drug mimics the metabolic and therapeutic effects of fasting, mice study shows

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.